S&P 500   3,924.51 (+0.02%)
DOW   31,418.19 (-0.23%)
QQQ   293.24 (+0.72%)
AAPL   139.16 (-1.18%)
MSFT   256.00 (+0.76%)
FB   193.84 (+0.83%)
GOOGL   2,232.24 (-0.26%)
AMZN   2,181.92 (+1.85%)
TSLA   719.77 (+1.40%)
NVDA   174.89 (+3.25%)
BABA   88.31 (+1.15%)
NIO   16.75 (+5.81%)
AMD   98.71 (+2.52%)
CGC   5.97 (+6.80%)
MU   70.58 (-0.66%)
T   20.26 (+0.15%)
GE   76.49 (+1.72%)
F   13.11 (+2.58%)
DIS   104.17 (-0.12%)
AMC   13.19 (+3.37%)
PFE   50.84 (+0.87%)
PYPL   82.18 (+6.48%)
NFLX   185.48 (+4.68%)
S&P 500   3,924.51 (+0.02%)
DOW   31,418.19 (-0.23%)
QQQ   293.24 (+0.72%)
AAPL   139.16 (-1.18%)
MSFT   256.00 (+0.76%)
FB   193.84 (+0.83%)
GOOGL   2,232.24 (-0.26%)
AMZN   2,181.92 (+1.85%)
TSLA   719.77 (+1.40%)
NVDA   174.89 (+3.25%)
BABA   88.31 (+1.15%)
NIO   16.75 (+5.81%)
AMD   98.71 (+2.52%)
CGC   5.97 (+6.80%)
MU   70.58 (-0.66%)
T   20.26 (+0.15%)
GE   76.49 (+1.72%)
F   13.11 (+2.58%)
DIS   104.17 (-0.12%)
AMC   13.19 (+3.37%)
PFE   50.84 (+0.87%)
PYPL   82.18 (+6.48%)
NFLX   185.48 (+4.68%)
S&P 500   3,924.51 (+0.02%)
DOW   31,418.19 (-0.23%)
QQQ   293.24 (+0.72%)
AAPL   139.16 (-1.18%)
MSFT   256.00 (+0.76%)
FB   193.84 (+0.83%)
GOOGL   2,232.24 (-0.26%)
AMZN   2,181.92 (+1.85%)
TSLA   719.77 (+1.40%)
NVDA   174.89 (+3.25%)
BABA   88.31 (+1.15%)
NIO   16.75 (+5.81%)
AMD   98.71 (+2.52%)
CGC   5.97 (+6.80%)
MU   70.58 (-0.66%)
T   20.26 (+0.15%)
GE   76.49 (+1.72%)
F   13.11 (+2.58%)
DIS   104.17 (-0.12%)
AMC   13.19 (+3.37%)
PFE   50.84 (+0.87%)
PYPL   82.18 (+6.48%)
NFLX   185.48 (+4.68%)
S&P 500   3,924.51 (+0.02%)
DOW   31,418.19 (-0.23%)
QQQ   293.24 (+0.72%)
AAPL   139.16 (-1.18%)
MSFT   256.00 (+0.76%)
FB   193.84 (+0.83%)
GOOGL   2,232.24 (-0.26%)
AMZN   2,181.92 (+1.85%)
TSLA   719.77 (+1.40%)
NVDA   174.89 (+3.25%)
BABA   88.31 (+1.15%)
NIO   16.75 (+5.81%)
AMD   98.71 (+2.52%)
CGC   5.97 (+6.80%)
MU   70.58 (-0.66%)
T   20.26 (+0.15%)
GE   76.49 (+1.72%)
F   13.11 (+2.58%)
DIS   104.17 (-0.12%)
AMC   13.19 (+3.37%)
PFE   50.84 (+0.87%)
PYPL   82.18 (+6.48%)
NFLX   185.48 (+4.68%)
NASDAQ:KERN

Akerna (KERN) Stock Forecast, Price & News

$0.42
+0.02 (+5.85%)
(As of 05/19/2022 03:02 PM ET)
Add
Compare
Today's Range
$0.40
$0.43
50-Day Range
$0.40
$1.37
52-Week Range
$0.39
$5.61
Volume
2,403 shs
Average Volume
401,066 shs
Market Capitalization
$14.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.6
30 days | 90 days | 365 days | Advanced Chart
Receive KERN News and Ratings via Email

Sign-up to receive the latest news and ratings for Akerna and its competitors with MarketBeat's FREE daily newsletter.

Akerna logo

About Akerna

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. Further, it provides cannabis cultivation management and compliance software; and cannabis tracking technology that offers seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KERN
Fax
N/A
Employees
204
Year Founded
N/A

Sales & Book Value

Annual Sales
$20.68 million
Book Value
$1.86 per share

Profitability

Net Income
$-31.33 million
Net Margins
-207.74%
Pretax Margin
-162.35%

Debt

Price-To-Earnings

Miscellaneous

Free Float
31,216,000
Market Cap
$14.59 million
Optionable
Not Optionable

Company Calendar

Last Earnings
5/09/2022
Today
5/19/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.75 out of 5 stars

Medical Sector

859th out of 1,418 stocks

Data Processing & Preparation Industry

59th out of 114 stocks

Analyst Opinion: 3.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -













Akerna (NASDAQ:KERN) Frequently Asked Questions

Is Akerna a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akerna in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Akerna stock.
View analyst ratings for Akerna
or view top-rated stocks.

When is Akerna's next earnings date?

Akerna is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Akerna
.

How were Akerna's earnings last quarter?

Akerna Corp. (NASDAQ:KERN) issued its quarterly earnings data on Monday, May, 9th. The company reported ($0.69) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.52. Akerna had a negative trailing twelve-month return on equity of 30.01% and a negative net margin of 207.74%. During the same quarter in the previous year, the business posted ($0.28) EPS.
View Akerna's earnings history
.

What price target have analysts set for KERN?

4 analysts have issued 1-year target prices for Akerna's shares. Their forecasts range from $1.50 to $8.00. On average, they anticipate Akerna's share price to reach $4.50 in the next twelve months. This suggests a possible upside of 973.5% from the stock's current price.
View analysts' price targets for Akerna
or view top-rated stocks among Wall Street analysts.

Who are Akerna's key executives?
Akerna's management team includes the following people:
  • Ms. Jessica Billingsley, Founder, CEO & Chairman (Age 45, Pay $250.74k)
  • Mr. Cecil Ray Thompson Jr., Pres & COO (Age 51, Pay $200k)
  • Mr. John Michael Fowle Jr., CFO & Sec. (Age 44, Pay $200k)
  • Mr. David R. McCullough, Chief Technology Officer (Age 46, Pay $200k)
  • Georgia Jablon, Communications Mang.
What other stocks do shareholders of Akerna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akerna investors own include KushCo (KSHB), OrganiGram (OGI), Supreme Cannabis (SPRWF), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Medical Marijuana (MJNA), MariMed (MRMD), Matinas BioPharma (MTNB), CNBX Pharmaceuticals (CNBX) and DHT (DHT).

What is Akerna's stock symbol?

Akerna trades on the NASDAQ under the ticker symbol "KERN."

Who are Akerna's major shareholders?

Akerna's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.37%), Bank of New York Mellon Corp (0.89%), Renaissance Technologies LLC (0.44%), Lindbrook Capital LLC (0.44%), GSA Capital Partners LLP (0.21%) and Vident Investment Advisory LLC (0.18%). Company insiders that own Akerna stock include Amy A Poinsett Revocable Livi, Jessica Billingsley and Matthew Ryan Kane.
View institutional ownership trends for Akerna
.

Which major investors are selling Akerna stock?

KERN stock was sold by a variety of institutional investors in the last quarter, including Simplex Trading LLC, GSA Capital Partners LLP, Renaissance Technologies LLC, Vanguard Group Inc., Dimensional Fund Advisors LP, Lindbrook Capital LLC, and Group One Trading L.P..
View insider buying and selling activity for Akerna
or view top insider-selling stocks.

Which major investors are buying Akerna stock?

KERN stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Vident Investment Advisory LLC, Levin Capital Strategies L.P., and Bank of Montreal Can.
View insider buying and selling activity for Akerna
or or view top insider-buying stocks.

How do I buy shares of Akerna?

Shares of KERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akerna's stock price today?

One share of KERN stock can currently be purchased for approximately $0.42.

How much money does Akerna make?

Akerna has a market capitalization of $14.45 million and generates $20.68 million in revenue each year. The company earns $-31.33 million in net income (profit) each year or ($1.63) on an earnings per share basis.

How many employees does Akerna have?

Akerna employs 204 workers across the globe.

What is Akerna's official website?

The official website for Akerna is www.akerna.com.

How can I contact Akerna?

Akerna's mailing address is 1601 ARAPAHOE STREET, DENVER CO, 80202. The company can be reached via phone at 888-932-6537 or via email at [email protected].

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.